Percutaneous left atrial appendage closure (LAAC) devices have emerged as an important
alternative to anticoagulation for stroke prevention in patients with atrial fibrillation.
National data on recent trends and early complication rates associated with endocardial
(endo) LAAC and epicardial (epi) LAAC procedures are limited.
To read this article in full you will need to make a payment
© 2021 Published by Elsevier Inc.